Literature DB >> 31778241

Lysophosphatidic acid receptor 4 regulates osteogenic and adipogenic differentiation of progenitor cells via inactivation of RhoA/ROCK1/β-catenin signaling.

Yan Xie1, Xiaochen Wang1, Xiaowen Wu1, Lijie Tian1, Jie Zhou1, Xiaoxia Li2, Baoli Wang1.   

Abstract

Recent evidence revealed that lysophosphatidic acid receptor 4 (LPAR4) plays a role in osteogenesis and bone remodeling in mice. However, the molecular mechanism by which LPAR4 controls osteogenic and adipogenic differentiation of mesenchymal progenitor cells remains pending. In the current study, our data showed that Lpar4 was expressed in bone and adipose tissue and the expression increased during osteoblast and adipocyte differentiation. Lpar4 overexpression in stromal ST2 and preosteoblastic MC3T3-E1 cells inhibited osteogenic differentiation. By contrast, Lpar4 overexpression in ST2 and mesenchymal C3H10T1/2 cells enhanced adipogenic differentiation. Conversely, depletion of endogenous Lpar4 in the progenitor cells induced osteogenic differentiation and inhibited adipogenic differentiation. Furthermore, enhanced osteoblast differentiation and alleviated fat accumulation were observed in marrow of mice after in vivo transfection of Lpar4 siRNA. Mechanism investigations revealed that LPAR4 inhibited the activation of ras homolog family member A (RhoA)/Rho-associated kinases 1 (ROCK1) and canonical Wnt signal pathways. ROCK1 was shown to be able to activate Wnt/β-catenin pathway. We further demonstrated that the overexpression of ROCK1 stimulated osteogenic differentiation and restrained adipogenic differentiation from stromal progenitor cells. Moreover, overexpression of ROCK1 attenuated the inhibition of osteogenic differentiation by LPAR4. The current study has provided evidences demonstrating that RhoA/ROCK1 activates β-catenin signaling to promote osteogenic differentiation and conversely restrain adipogenic differentiation. The inactivation of RhoA/ROCK1/β-catenin signaling is involved in LPAR4 regulation of the directional differentiation of marrow stromal progenitor cells. ©AlphaMed Press 2019.

Entities:  

Keywords:  adipocyte; lysophosphatidic acid receptor 4; osteoblast; ras homolog family member a; rho-associated kinases 1; β-catenin

Mesh:

Substances:

Year:  2019        PMID: 31778241     DOI: 10.1002/stem.3128

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  6 in total

1.  Single-cell RNA sequencing unravels heterogeneity of skeletal progenitors and cell-cell interactions underlying the bone repair process.

Authors:  Mika Nakayama; Hiroyuki Okada; Masahide Seki; Yutaka Suzuki; Ung-Il Chung; Shinsuke Ohba; Hironori Hojo
Journal:  Regen Ther       Date:  2022-05-18       Impact factor: 3.651

2.  The novel long noncoding RNA lncRNA-Adi regulates adipogenesis.

Authors:  Yuanwei Chen; Kaide Li; Xiao Zhang; Jinlong Chen; Meisheng Li; Lei Liu
Journal:  Stem Cells Transl Med       Date:  2020-05-01       Impact factor: 6.940

3.  Platelet-Rich Fibrin Decreases the Inflammatory Response of Mesenchymal Cells.

Authors:  Zahra Kargarpour; Jila Nasirzade; Layla Panahipour; Richard J Miron; Reinhard Gruber
Journal:  Int J Mol Sci       Date:  2021-10-20       Impact factor: 6.208

4.  LncRNA DLGAP1-AS1 accelerates glioblastoma cell proliferation through targeting miR-515-5p/ROCK1/NFE2L1 axis and activating Wnt signaling pathway.

Authors:  Zixuan Wang; Yipeng Han; Qifeng Li; Baocheng Wang; Jie Ma
Journal:  Brain Behav       Date:  2021-09-18       Impact factor: 2.708

Review 5.  Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders.

Authors:  Candide Alioli; Léa Demesmay; Olivier Peyruchaud; Irma Machuca-Gayet
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

6.  Lysophosphatidic Acid Induced Apoptosis, DNA Damage, and Oxidative Stress in Spinal Cord Neurons by Upregulating LPA4/LPA6 Receptors.

Authors:  Yifan Yang; Jing Xu; Qingxin Su; Yiran Wu; Qizheng Li; Zongren Ma; Tao Ding
Journal:  Mediators Inflamm       Date:  2022-09-30       Impact factor: 4.529

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.